Investigates 4-methoxyhydroxybenzene determination in biomatrices, suggesting effective methods for identification and quantification.
OBJECTIVE: To investigate the features of the chemical and toxicological determination of 4-methoxyhydroxybenzene (4-MOHOB). MATERIAL AND METHODS: The methods of the study were TLC, reversed-phase column chromatography of ordinary pressure, GC-MS and HPLC. 4-MOHOB was isolated from liver tissue and blood by infusion with a mixture of ethyl «acetate-acetone» (7:3). RESULTS: The expediency of eluting the analyte from the Silasorb C18 column (150×10 mm) with the mobile phase of «acetonitrile-water» (4:6) was shown, which in combination with extraction formed the basis for the developed version of purification of 4-MOHOB extracted from biomatrices. The advantages of the «hexane-ether» (6:4) mobile phase in the identification of 4-MOHOB by TLC (Merck plates) were proven. One of the variants of 4-MOGOB identification is based on its extinction properties (UV range; medium - 95% ethanol). GC-MS (mobile phase - helium, stationary phase «5% phenyl-95% methylpolysiloxane» in a column measuring 25 m × 0.2 mm) was used as the main method of confirmatory identification of 4-MOGOB. The mass spectrum of this compound included signals of the following ions (m/z): 38, 53, 65, 81, 109, 124. A 250×4.6 mm Discovery C 18 column and an eluent of «acetonitrile-acid-water solution with a pH of 5.5» (50:50) were proposed for determining 4-MOGOB by HPLC. CONCLUSION: The compliance of the developed methods with the key validation parameters was confirmed. The detection limits of 4-MOHOB in 100 g of organ (liver) and blood are 0.08 and 0.06 mg, respectively, the limits of quantitative determination are 0.14 and 0.10 mg.
No takes yet. Share an insight, caveat, or question.
Chernova et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: